Applications are invited from suitable candidates for filling up the purely temporary positions of two Research Associate-I, one each in the DBT Multi-institutional project entitled “Biotechnological interventions for revitalizing sustainable large cardamom (Amomum subulatum Roxb.) cultivation”, and BMGF-Gates Foundation-funded project entitled “Development of Climate resilient chickpea and brassica by gene editing”, under the supervision of Dr. Debasis Chattopadhya, Director, BRIC-NIPGR. The details of positions are as under :

India is aiming to achieve pharmaceutical exports worth USD 50 billion by 2030, driven by a strong focus on quality manufacturing, innovation, regulatory excellence, and international collaboration. The vision was highlighted during discussions involving global drug regulators, industry leaders, and policymakers, underscoring India's ambition to strengthen its position as a leading supplier of medicines to the world.

In a major advancement for HIV treatment, Gilead Sciences and Merck have announced positive topline results from two pivotal Phase 3 clinical trials evaluating an investigational once-weekly oral HIV therapy that combines islatravir and lenacapavir. The promising findings bring the healthcare industry one step closer to introducing what could become the world's first long-acting oral HIV treatment taken just once a week.

A groundbreaking European clinical trial has shown that using a common, harmless virus as a biomarker to guide immunosuppressive treatment after kidney transplantation is both safe and effective, paving the way for more personalized transplant care.